GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage

Phase 1

Completed

Conditions: Tendon Injuries

Interventions: Drug: GSK1278863
Drug: Placebo

First Posted Date: 2014-09-04

Last Posted Date: 2017-05-09

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 26

Registration Number: NCT02231190

Locations: 🇺🇸
GSK Investigational Site, Baltimore, Maryland, United States

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Phase 3

Withdrawn

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Albiglutide
Drug: Matching albiglutide placebo

First Posted Date: 2014-09-01

Last Posted Date: 2016-01-11

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT02229240

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Phase 3

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Albiglutide
Drug: Insulin Glargine and Insulin Lispro

First Posted Date: 2014-09-01

Last Posted Date: 2020-11-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 814

Registration Number: NCT02229227

Locations: 🇬🇧
GSK Investigational Site, Sidcup, United Kingdom

Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity

Phase 2

Completed

Conditions: Dentin Sensitivity

Interventions: Drug: Potassium nitrate and sodium fluoride
Drug: Standard fluoride dentifrice

First Posted Date: 2014-08-27

Last Posted Date: 2018-08-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 191

Registration Number: NCT02226562

Locations: 🇺🇸
GSK Investigational Site, Fort Wayne, Indiana, United States

GSK2190915A - Bioavailability Study

Phase 1

Completed

Conditions: Asthma

Interventions: Drug: GSK2190915 Solution.
Drug: GSK2190915 Milled Tablet
Drug: GSK2190915 Granule Capsule (A)
Drug: GSK2190915 Micronised Tablet
Drug: GSK2190915 Semi-solid Lipid Capsule (B)
Drug: GSK2190915 Liquid Lipid Capsule (C)